Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 113751-113800 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT02615457
Huaier Granule in Treating Women With Triple Negative Breast Cancer
PHASE4
Recruiting
300 participants
Started: Oct 31, 2015
1 condition
1 sponsor
1 location
NCT02543710
Biomarker Guided Treatment in Gynaecological Cancer
PHASE4
Recruiting
1,300 participants
Started: Oct 31, 2015 · Completed: Dec 31, 2033
1 condition
1 sponsor
9 locations
NCT03052114
Electrical Impedance Tomography of Stroke and Brain Injury
N/A
Active, not recruiting
150 participants
Started: Oct 31, 2015 · Completed: Dec 31, 2027
2 conditions
2 sponsors
1 location
NCT02591563
Evaluate Pathogens and Immunity to Acute Otitis Media in Healthy Children.
N/A
Active, not recruiting
1,320 participants
Started: Oct 31, 2015 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT02573532
Incidence and Outcome of Perioperative Myocardial Injury After Non-cardiac Surgery
N/A
Active, not recruiting
16,204 participants
Started: Oct 31, 2015 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT02633111
DNA Sequencing-Based Monitoring of Minimal Residual Disease to Predict Clinical Relapse in Aggressive B-cell Non-Hodgkin Lymphomas
N/A
Active, not recruiting
501 participants
Started: Oct 31, 2015 · Completed: Oct 31, 2025
2 conditions
5 sponsors
12 locations
NCT02791152
Effects of Physical Activity, Ambulatory Blood Pressure and Calcium Score on Cardiovascular Health in Normal People
N/A
Recruiting
1,000 participants
Started: Oct 31, 2015 · Completed: Dec 31, 2036
1 condition
1 sponsor
1 location
NCT02592083
Neoadjuvant Response-guided Treatment of Slowly Proliferating Hormone Receptor Positive Tumors
PHASE2
Active, not recruiting
10 participants
Started: Oct 31, 2015 · Completed: Feb 28, 2029
2 conditions
1 sponsor
1 location
NCT02449252
Efficacy of Consolidative Involved-site Radiotherapy for Patients With Limited-stage Follicular Lymphoma
PHASE3
Recruiting
120 participants
Started: Oct 31, 2015 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT02649959
An Open Label Study of CM-AT for the Treatment of Children With Autism
PHASE3
Active, not recruiting
405 participants
Started: Oct 31, 2015 · Completed: Jan 31, 2028
1 condition
1 sponsor
31 locations
NCT02627248
Neoadjuvant Chemotherapy With or Without Huaier Granule in Treating Women With Locally Advanced Breast Cancer That Can Be Removed By Surgery
PHASE4
Recruiting
200 participants
Started: Oct 31, 2015 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT02570802
Ultrasonographic Reference Values for Peripheral Nerves in Children
NA
Recruiting
255 participants
Started: Oct 31, 2015 · Completed: Dec 31, 2024
1 condition
2 sponsors
1 location
NCT02449278
The Palliative Benefit of Involved-site Radiotherapy for Patients With Advanced-stage Diffuse Large B-cell Lymphoma
PHASE3
Recruiting
120 participants
Started: Oct 31, 2015 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT02609269
Decipher Genomics Resource for Intelligent Discovery
N/A
Enrolling by invitation
1,000,000 participants
Started: Oct 31, 2015 · Completed: Dec 31, 2040
3 conditions
2 sponsors
0 locations
NCT02194842
Phase III Radium 223 mCRPC-PEACE III
PHASE3
Active, not recruiting
446 participants
Started: Oct 31, 2015 · Completed: Dec 31, 2028
1 condition
7 sponsors
64 locations
NCT02579408
Quantifying Steatosis in Liver Transplant Donors
N/A
Active, not recruiting
100 participants
Started: Oct 31, 2015 · Completed: May 31, 2026
2 conditions
1 sponsor
1 location
NCT02353819
Stereotactic Ablative Radiotherapy (SABR) of Pelvis and Prostate Targets For High Risk Prostate Cancer
PHASE1
Active, not recruiting
60 participants
Started: Oct 31, 2015 · Completed: Dec 31, 2030
1 condition
2 sponsors
1 location
NCT02573415
Uterine Transplantation for the Treatment of Uterine Factor Infertility
NA
Enrolling by invitation
10 participants
Started: Oct 31, 2015 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT02520713
The iCat2, GAIN (Genomic Assessment Informs Novel Therapy) Consortium Study
N/A
Active, not recruiting
825 participants
Started: Oct 31, 2015 · Completed: Oct 31, 2026
1 condition
1 sponsor
12 locations
NCT02422563
NeoAdjuvant Chemotherapy Followed by Radical Hysterectomy (OP) Versus Primary Chemo-RADiation in Cervical Cancer FIGO Stage IB2 and IIB
PHASE3
Not yet recruiting
534 participants
Started: Oct 31, 2015 · Completed: Oct 31, 2025
1 condition
1 sponsor
0 locations
NCT02566200
French Registry of Acute ST-elevation or Non-ST-elevation Myocardial Infarction 2015
N/A
Active, not recruiting
5,000 participants
Started: Oct 31, 2015 · Completed: Oct 31, 2027
1 condition
2 sponsors
1 location
NCT02343042
Selinexor and Backbone Treatments of Multiple Myeloma Patients
PHASE1/PHASE2
Recruiting
300 participants
Started: Oct 31, 2015 · Completed: Apr 30, 2027
1 condition
2 sponsors
24 locations
NCT02600208
Peripheral Blood Stem Cell Transplantation for Hematologic Malignancies with Alpha Beta TCell and B Cell Depletion Using the CliniMACS Device
PHASE2/PHASE3
Active, not recruiting
60 participants
Started: Oct 31, 2015 · Completed: Dec 31, 2026
1 condition
2 sponsors
1 location
NCT02215265
Post-operative Adjuvant Treatment for HPV-positive Tumours (PATHOS)
PHASE3
Active, not recruiting
1,269 participants
Started: Oct 31, 2015 · Completed: Apr 30, 2028
1 condition
6 sponsors
57 locations
NCT02952144
Post Approval Study of Lixelle for the Treament of Dialysis-Related Amyloidosis
NA
Recruiting
40 participants
Started: Oct 31, 2015 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT02573753
The Effects of Sleep on Human Microbiota: Implications for Health and Disease
NA
Recruiting
5,000 participants
Started: Oct 31, 2015 · Completed: Dec 31, 2031
1 condition
1 sponsor
1 location
NCT02344680
Liver Fibrosis in Zambian HIV-HBV Co-infected Patients
N/A
Active, not recruiting
303 participants
Started: Oct 31, 2015 · Completed: Apr 30, 2026
7 conditions
3 sponsors
1 location
NCT02577926
The Ruxo-BEAT Trial in Patients With High-risk Polycythemia Vera or High-risk Essential Thrombocythemia
PHASE2
Active, not recruiting
207 participants
Started: Oct 31, 2015 · Completed: Dec 31, 2028
2 conditions
2 sponsors
23 locations
NCT02804815
Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours
PHASE3
Active, not recruiting
11,000 participants
Started: Oct 31, 2015 · Completed: Oct 31, 2026
5 conditions
1 sponsor
82 locations
NCT02542657
Ixazomib with Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients with Multiple Myeloma
PHASE1/PHASE2
Active, not recruiting
30 participants
Started: Oct 31, 2015 · Completed: Dec 31, 2025
1 condition
3 sponsors
3 locations
NCT02588989
Fibrosis, Valvular and Ventricular Function in Patients With TGA
N/A
Active, not recruiting
37 participants
Started: Oct 31, 2015 · Completed: Jun 30, 2027
1 condition
1 sponsor
1 location
NCT02646839
KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children
PHASE2
Enrolling by invitation
50 participants
Started: Oct 31, 2015 · Completed: Dec 31, 2025
3 conditions
9 sponsors
11 locations
NCT02578446
Uncemented Tritanium Compared With Cemented Metal-backed Tibia Components in Total Knee Replacement
NA
Active, not recruiting
72 participants
Started: Oct 31, 2015 · Completed: Mar 31, 2027
3 conditions
3 sponsors
2 locations
NCT02486718
Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010]
PHASE3
Active, not recruiting
1,280 participants
Started: Oct 31, 2015 · Completed: Aug 30, 2035
1 condition
1 sponsor
153 locations
NCT02593994
IRIS-Onyx Cohort in the IRIS-DES Registry
N/A
Recruiting
4,500 participants
Started: Oct 31, 2015 · Completed: Dec 31, 2029
4 conditions
3 sponsors
33 locations
NCT04071327
Pulmonary Hypertension Association Registry
N/A
Recruiting
3,000 participants
Started: Oct 31, 2015 · Completed: Dec 31, 2025
3 conditions
1 sponsor
52 locations
NCT02632422
AIH-induced Walking Recovery After Subacute SCI
NA
Active, not recruiting
125 participants
Started: Oct 31, 2015 · Completed: Dec 30, 2024
1 condition
2 sponsors
2 locations
NCT02438501
Efficacy of Palliative Low-Dose Involved-Field Radiation Therapy for Recurrent Advanced Follicular Lymphoma
PHASE3
Recruiting
166 participants
Started: Oct 31, 2015 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT02693496
Mobile Lung Nodule Observatory for Worldwide, Evidenced-based Research
N/A
Recruiting
10,000 participants
Started: Oct 31, 2015 · Completed: Oct 31, 2025
1 condition
1 sponsor
34 locations
NCT02446093
Neoadjuvant CAN-2409 in Combination With Chemoradiation or SBRT for Borderline Resectable Pancreatic Adenocarcinoma
PHASE2
Active, not recruiting
54 participants
Started: Oct 31, 2015 · Completed: Jul 31, 2026
1 condition
2 sponsors
3 locations
NCT02862418
Imaging of Lungs With a New Type of Magnetic Resonance Imaging (MRI) Called UTE (Ultrashort Echo Time)
N/A
Recruiting
150 participants
Started: Oct 31, 2015 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT02339779
Breast Reconstruction With External Pre-expansion and Autologous Fat Transfer Versus Standard Therapy
NA
Active, not recruiting
196 participants
Started: Oct 31, 2015 · Completed: Oct 31, 2026
1 condition
2 sponsors
7 locations
NCT02521844
A Study to Evaluate the Safety and Tolerability of ETC-1922159 as a Single Agent and in Combination With Pembrolizumab in Advanced Solid Tumours
PHASE1
Active, not recruiting
89 participants
Started: Oct 31, 2015 · Completed: Oct 31, 2024
1 condition
2 sponsors
11 locations
NCT02557321
PV-10 in Combination With Pembrolizumab for Treatment of Metastatic Melanoma
PHASE1/PHASE2
Active, not recruiting
50 participants
Started: Oct 31, 2015 · Completed: Apr 30, 2025
1 condition
1 sponsor
5 locations
NCT02570542
Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)
PHASE2
Active, not recruiting
59 participants
Started: Oct 31, 2015 · Completed: Oct 31, 2025
3 conditions
8 sponsors
14 locations
NCT02449265
Efficacy of Consolidative Involved-site Radiotherapy for Patients With Limited-stage Diffuse Large B-cell Lymphoma
PHASE3
Recruiting
160 participants
Started: Oct 31, 2015 · Completed: Oct 31, 2025
1 condition
1 sponsor
1 location
NCT02437396
Oxidative Stress and Inflammatory Biomarkers in Gaucher Disease
N/A
Recruiting
34 participants
Started: Oct 31, 2015 · Completed: Feb 28, 2026
3 conditions
1 sponsor
1 location
NCT05852418
Registry Study of Assistive Devices, Medicines and Healthcare Measures in ALS, SMA and Other Neurological Diseases.
N/A
Recruiting
25,000 participants
Started: Oct 30, 2015 · Completed: Jun 30, 2029
1 condition
2 sponsors
16 locations
NCT02562235
Riociguat in Children With Pulmonary Arterial Hypertension (PAH)
PHASE3
Active, not recruiting
24 participants
Started: Oct 29, 2015 · Completed: Aug 3, 2027
1 condition
2 sponsors
16 locations
NCT02436707
Novel Combination Therapy in the Treatment of Relapsed and Refractory Aggressive B-Cell Lymphoma
PHASE2
Active, not recruiting
129 participants
Started: Oct 27, 2015 · Completed: Dec 31, 2026
1 condition
4 sponsors
12 locations
Previous
1
More pages
2273
2274
2275
2276
2277
2278
2279
More pages
2369
Next